Taiwan · Delayed Price · Currency is TWD Anxo Pharmaceutical Statistics
Total Valuation
TPEX:6677 has a market cap or net worth of TWD 988.92 million. The enterprise value is 1.48 billion.
| Market Cap | 988.92M |
| Enterprise Value | 1.48B |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6677 has 55.87 million shares outstanding. The number of shares has increased by 0.30% in one year.
| Current Share Class | 55.87M |
| Shares Outstanding | 55.87M |
| Shares Change (YoY) | +0.30% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 4.05% |
| Owned by Institutions (%) | 9.53% |
| Float | 28.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.17 |
| PB Ratio | 0.89 |
| P/TBV Ratio | 1.04 |
| P/FCF Ratio | 130.14 |
| P/OCF Ratio | 17.87 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 47.07, with an EV/FCF ratio of 194.35.
| EV / Earnings | -43.27 |
| EV / Sales | 1.75 |
| EV / EBITDA | 47.07 |
| EV / EBIT | n/a |
| EV / FCF | 194.35 |
Financial Position
The company has a current ratio of 1.57, with a Debt / Equity ratio of 0.66.
| Current Ratio | 1.57 |
| Quick Ratio | 1.02 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | 23.42 |
| Debt / FCF | 96.72 |
| Interest Coverage | -2.63 |
Financial Efficiency
Return on equity (ROE) is -3.13% and return on invested capital (ROIC) is -2.95%.
| Return on Equity (ROE) | -3.13% |
| Return on Assets (ROA) | -1.31% |
| Return on Invested Capital (ROIC) | -2.95% |
| Return on Capital Employed (ROCE) | -2.86% |
| Weighted Average Cost of Capital (WACC) | 4.41% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.40 |
| Inventory Turnover | 2.10 |
Taxes
| Income Tax | -10.47M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.35% in the last 52 weeks. The beta is 0.38, so TPEX:6677's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -5.35% |
| 50-Day Moving Average | 19.01 |
| 200-Day Moving Average | 21.09 |
| Relative Strength Index (RSI) | 39.09 |
| Average Volume (20 Days) | 76,170 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6677 had revenue of TWD 843.26 million and -34.13 million in losses. Loss per share was -0.61.
| Revenue | 843.26M |
| Gross Profit | 300.18M |
| Operating Income | -43.69M |
| Pretax Income | -45.60M |
| Net Income | -34.13M |
| EBITDA | 17.22M |
| EBIT | -43.69M |
| Loss Per Share | -0.61 |
Balance Sheet
The company has 363.37 million in cash and 734.97 million in debt, with a net cash position of -371.60 million or -6.65 per share.
| Cash & Cash Equivalents | 363.37M |
| Total Debt | 734.97M |
| Net Cash | -371.60M |
| Net Cash Per Share | -6.65 |
| Equity (Book Value) | 1.11B |
| Book Value Per Share | 17.75 |
| Working Capital | 308.45M |
Cash Flow
In the last 12 months, operating cash flow was 55.34 million and capital expenditures -47.74 million, giving a free cash flow of 7.60 million.
| Operating Cash Flow | 55.34M |
| Capital Expenditures | -47.74M |
| Depreciation & Amortization | 60.92M |
| Net Borrowing | -4.83M |
| Free Cash Flow | 7.60M |
| FCF Per Share | 0.14 |
Margins
Gross margin is 35.60%, with operating and profit margins of -5.18% and -4.05%.
| Gross Margin | 35.60% |
| Operating Margin | -5.18% |
| Pretax Margin | -5.41% |
| Profit Margin | -4.05% |
| EBITDA Margin | 2.04% |
| EBIT Margin | -5.18% |
| FCF Margin | 0.90% |
Dividends & Yields
TPEX:6677 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.30% |
| Shareholder Yield | -0.30% |
| Earnings Yield | -3.45% |
| FCF Yield | 0.77% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 1, 2021. It was a forward split with a ratio of 1.05.
| Last Split Date | Nov 1, 2021 |
| Split Type | Forward |
| Split Ratio | 1.05 |
Scores
TPEX:6677 has an Altman Z-Score of 1.25 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.25 |
| Piotroski F-Score | 3 |